Progress in the preoperative diagnosis of thyroid nodules: managing uncertainties and the ultimate role for molecular investigation

Biomedicine and Pharmacotherapy

Volumn 60, Issue 8, 2006, Pages 396-404

  Mechanick, J I ^a   Carpi, A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

BRAF; Thyroid FNA; Thyroid nodules; Thyroid ultrasond

Indexed keywords

MOLECULAR MARKER; THYROTROPIN;

ALGORITHM; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CARCINOGENESIS; CLINICAL ASSESSMENT; DELAYED DIAGNOSIS; ECHOGRAPHY; HUMAN; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; THYROID CANCER; THYROID NODULE; THYROTROPIN BLOOD LEVEL; TREATMENT PLANNING; BLOOD; DIAGNOSTIC PROCEDURE; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; PREOPERATIVE CARE; REVIEW; THYROID GLAND; THYROID TUMOR;

BIOPSY, FINE-NEEDLE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PRACTICE GUIDELINES; PREOPERATIVE CARE; RISK FACTORS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROTROPIN;

EID: 33748899892     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.07.006     Document Type: Short Survey

References (133)

1. Wiest P.W., Hartshorne M.F., Inskip P.D., Crooks L.A., Vela B.S., Telepak R.J., et al. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J. Ultrasound Med. 17 (1998) 487-496
2. Carroll B.A. Asymptomatic thyroid nodules: incidental sonographic detection. AJR Am. J. Roentgenol. 138 (1982) 499-501
3. Brander A., Viikinkoski P., Nickels J., and Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology 181 (1991) 683-687
4. Bruneton J.N., Balu-Maestro C., Marcy P.Y., Melia P., and Mourou M.Y. Very high frequency (13 MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J. Ultrasound Med. 13 (1994) 87-90
5. Horlocker T.T., and Hay I.D. Prevalence of incidental nodular thyroid disease detected during high-resolution parathyroid sonography. In: Medeiros-Neto G., and Gaitan E. (Eds). Frontiers in thyroidology, vol. 2 (1985), Plenum, New York, NY 1309-1312
6. Mortenson J.D., Woolner L.B., and Bennett W.A. Gross and microscopic findings in clinically normal thyroid glands. J. Clin. Endocrinol. Metab. 15 (1955) 1270-1280
7. Tan G.H., and Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann. Intern. Med. 126 (1997) 226-231
8. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J. Clin. 56 (2006) 106-130
9. Papini E., Guglielmi R., Bianchini A., Crescena A., Taccogna S., Nardi F., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color Doppler features. J. Clin. Endocrinol. Metab. 87 (2002) 1941-1946
10. Hegedus L., Bonnema S.J., and Bennedbaek F.N. Mangement of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24 (2003) 102-132
11. Frates M.C., Benson C.B., Doublet P.M., Kunreuther E., Contreras M., Cibas E.S., et al. Prevalence and Distribution of Carcinoma in Patients with Solitary and Multiple Thyroid Nodules on Sonography. J Clin Endocrinal Metab (2006)
12. Nam-Goong I.S., Kim H.Y., Gong G., Lee H.K., Hong S.J., Kim W.B., et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin. Endocrinol. (Oxf.) 60 (2004) 21-28
13. Hermus A.R. Clinical manifestations and treatment of non-toxic diffuse and nodular goiter. In: Braverman L.E., Utiger R.D., Ingbar S.H., and Werner S.C. (Eds). Werner and Ingbar's the thyroid: a fundamental and clinical text (2000), Lippincott Williams and Wilkins, Philadelphia, PA 867
14. Liebeskind A., Sikora A.G., Komisar A., Slavit D., and Fried K. Rates of malignancy in incidentally discovered thyroid nodules evaluated with sonography and fine-needle aspiration. J. Ultrasound Med. 24 (2005) 629-634
15. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J. Clin. 56 (2006) 106-130
16. Gilliland F.D., Hunt W.C., Morris D.M., and Key C.R. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-1991. Cancer 79 (1997) 564-573
17. Utiger R.D. The multiplicity of thyroid nodules and carcinomas. N. Engl. J. Med. 352 23 (2005) 2376-2378
18. Hay I.D. Papillary thyroid carcinoma. Endocrinol. Metab. Clin. North Am. 19 (1990) 545-576
19. Sdano M.T., Falciglia M., Welge J.A., and Steward D.L. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials. Otolaryngol. Head Neck Surg. 133 (2005) 391-396
20. Barbaro D., Macchia E., Orsini P., Piazza F., Lapi P., and Pasquini C. Assay of free thyroxine and free triiodothyronine in fine-needle aspiration of thyroid nodules: a useful and low-cost assessment. Endocr. Pract. 10 (2004) 311-316
21. Goretzki P., Wahl R.A., Branscheid D., Joseph K., Tsuchiya A., and Roher H.D. Indication for operation of patients with autonomously functioning thyroid tissue in endemic goiter areas. World J. Surg. 9 (1985) 149-155
22. Smith M., McHenry C., Jarosz H., Lawrence A.M., and Paloyan E. Carcinoma of the thyroid in patients with autonomous nodules. Am. Surg. 54 (1988) 448-449
23. Croom III R.D., Thomas Jr. C.G., Reddick R.L., and Tawil M.T. Autonomously functioning thyroid nodules in childhood and adolescence. Surgery 102 (1987) 1101-1108
24. Belfiore A., La Rosa G.L., La Porta G.A., Giuffrida D., Milazzo G., Lupo L., et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am. J. Med. 93 (1992) 359-362
25. Lin J.D., Chao T.C., Huang B.Y., Chen S.T., Chang H.Y., and Hsueh C. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid 15 (2005) 708-717
26. Krohn K., and Paschke R. Progress in understanding the etiology of thyroid autonomy. J. Clin. Endocrinol. Metab. 86 (2001) 3336-3345
27. Mechanick J.I. Diagnosis and management of nodular thyroid disease. In: Gagner M., Pertsemlidis D., and Schwartz A. (Eds). Endocrine surgery (2003), Marcel Dekker, Inc., New York 115-131
28. Alexander E.K., Marqusee E., Orcutt J., Benson C.B., Frates M.C., Doubilet P.M., et al. Thyroid nodule shape and prediction of malignancy. Thyroid 14 (2004) 953-958
29. Chammas M.C., Gerhard R., Souza de Oliveira I.R., Widman A., de Barros N., Durazzo M., et al. Thyroid nodules: evaluation with power Doppler and duplex Doppler ultrasound. Otolaryngol. Head Neck Surg. 132 (2005) 874-882
30. Cappelli C., Pirola I., Cumetti D., Micheletti L., Tironi A., Gandossi E., et al. Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonogaphic criteria for recommending fine-needle aspiration cytology?. Clin. Endocrinol. (Oxf.) 63 (2005) 689-693
31. Kim E., Park C.S., Chung W.Y., Oh K.K., Kim D.I., Lee J.T., et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR 178 (2002) 687-691
32. Ballantone R., Lombardi C., Raffaelli M., Traini E., Crea C., Rossi E., et al. Management of cystic thyroid nodules: the role of ultrasound-guided fine-needle aspiration biopsy. Thyroid 14 (2004) 43-47
33. Brauer V.F., Eder P., Miehle K., Wiesner T.D., Hasenclever H., and Paschke R. Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid 15 (2005) 1169-1175
34. Alexander E.K., Hurwitz S., Heering J.P., Benson C.B., Frates M.C., Doubilet P.M., et al. Natural history of benign solid and cystic thyroid nodules. Ann. Intern. Med. 138 (2003) 315-318
35. Papini E., Patrucci L., Guglielmi R., Panunzi C., Rinaldo R., Bacci V., et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J. Clin. Endocrinol. Metab. 83 (1998) 780-783
36. Brander A.E., Viikinkoski V.P., Nickels J.I., and Kivisaari L.M. Importance of thyroid abnormalities detected at US screening: a 5-year follow-up. Radiology 215 (2000) 801-806
37. Kuma K., Matsuzuka F., and Yobayashi A. Outcome of longstanding solitary thyroid nodules. World J. Surg. 16 (1992) 583-588
38. Kuma K., Matsuzuka F., Yokozawa T., Miyauchi A., and Sugawara M. Fate of untreated benign thyroid nodules: results of long-term followup. World J. Surg. 18 (1994) 495-499
39. Stulak J.M., Grant C.S., Farley D.R., Thompson G.B., van Heerden J.A., Hay I.D., et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg. 141 (2006) 489-494
40. Khurana K.K., Richards V.I., Chopra P.S., Izquierdo R., Rubens D., and Mesonero C. The role of ultrasonography-guided fine-needle aspiration biopsy in the management of nonpalpable and palpable thyroid nodules. Thyroid 8 (1998) 511-515
41. Solymosi T., Toth G.L., and Bodo M. Diagnostic accuracy of fine needle aspiration cytology of the thyroid: impact of ultrasonography and ultrasonographically guided aspiration. Acta Cytol. 45 (2001) 669-674
42. Yokozawa T., Fukata S., Kuma K., Matsuzuka F., Kobayashi A., Hirai K., et al. Thyroid cancer detected by ultrasound-guided fine-needle aspiration biopsy. World J. Surg. 20 (1996) 848-853
43. Weidman J., Chaubal A., and Bibbo M. Cellular fixation. A study of CytoRich Red and cytospin collection fluid. Acta Cytol. 41 (1997) 182-187
44. Malle D., Valeri R.M., Pazaitou-Panajiotou K., Kiziridou A., Vainas I., and Destouni C. Use of a thin-layer technique in thyroid fine needle aspiration. Acta Cytol. 50 (2006) 23-27
45. Faquin W.C., Cibas E.S., and Renshaw A.A. "Atypical" cells in fine-needle aspiration biopsy specimens of benign thyroid cysts. Cancer 105 (2005) 71-79
46. Gharib H., and Goellner J.R. Fine needle aspiration biopsy of the thyroid: an appraisal. Ann. Intern. Med. 118 (1993) 282-289
47. Khalid A.N., Hollenbeak C.S., Quraishi S.A., Fan C.Y., and Stack B.C. The cost-effectiveness of iodine 131 scintigraphy, ultrasonography, and fine-needle aspiration biopsy in the initial diagnosis of solitary thyroid nodules. Arch. Otolaryngol. Head Neck Surg. 132 (2006) 244-250
48. Belfiore A., and La Rosa G.L. Fine-needle aspiration biopsy of the thyroid. Endocr. Metab. Clin. North Am. 30 (2001) 361-400
49. Bakhos R., Selvaggi S.M., DeJong S., Gordon D.L., Pitale S.U., Herrmann M., et al. Fine-needle aspiration of the thyroid: rate and causes of cytohistopathologic discordance. Diagn. Cytopathol. 23 (2000) 233-237
50. Amrikachi M., Ponder T.B., Wheeler T.M., Smith D., and Ramzy I. Thyroid fine-needle aspiration biopsy in children and adolescents: experience with 218 aspirates. Diagn. Cytopathol. 32 (2005) 189-192
51. Chen H., Nicol T.L., Rosenthal D.L., and Udelsman R. The role of fine-needle aspirations in the evaluation of thyroid nodules. Prob. Gen. Surg. 14 (1997) 1-13
52. Gharib H., Goellner J.R., and Johnson D.A. Fine-needle aspiration cytology of the thyroid: a 12 year experience with 11,000 biopsies. Clin. Lab. Med. 13 (1993) 699-709
53. Kessler A., Gavriel H., Zahav S., Vaiman M., Shlamkovitch N., Segal S., et al. Accuracy and consistency of fine-needle aspiration biopsy in the diagnosis and management of solitary thyroid nodules. Isr. Med. Assoc. J. 7 (2005) 371-373
54. Furlan J.C., Bedard Y.C., and Rosen I.B. Single versus sequential fine-needle aspiration biopsy in the management of thyroid nodular disease. Can. J. Surg. 48 (2005) 12-18
55. Orija I.B., Hamrahian A.H., and Reddy S.S. Management of nondiagnostic thyroid fine-needle aspiration biopsy: survey of endocrinologists. Endocr. Pract. 10 (2004) 317-323
56. Goellner J.R., Gharib H., Grant C.S., and Johnson D.A. Fine needle aspiration cytology of the thyroid 1980-1986. Acta Cytol. 31 (1987) 587-590
57. Chehade J.M., Silverberg A.B., Kim J., Case C., and Mooradian A.D. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr. Pract. 7 (2001) 237-243
58. Sabel M.S., Haque D., Velasco J.M., and Staren E.D. Use of ultrasound-guided fine needle aspiration biopsy in the management of thyroid disease. Am. Surg. 64 (1998) 738-742 [with discussion]
59. Leenhardt L., Hejblum G., Franc B., Fediaevsky L.D., Delbot T., Le Guillouzic D., et al. Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J. Clin. Endocrinol. Metab. 84 (1999) 24-28
60. Accurso A., Rocco N., Palumbo A., and Leone F. Usefulness of ultrasound-guided fine needle aspiration cytology in the diagnosis of non-palpable small thyroid nodules. Tumori 91 (2005) 355-357
61. Kelly N.P., Lim J.C., DeJong S., Harmath C., Dudiak C., and Wojcik E.M. Specimen adequacy and diagnostic specificity of ultrasound-guided fine needle aspirations of nonpalpable thyroid nodules. Diagn. Cytopathol. 34 (2006) 188-190
62. Musgrave Y.M., Davey D.D., and Weeks J.A. Assessment of fine-needle aspiration sampling technique in thyroid nodules. Diagn. Cytopathol. 18 (1998) 76-80
63. Baloch Z.W., and LiVolsi V.A. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod. Pathol. 13 (2000) 861-865
64. Karstrup S., Balslev E., Juul N., Eskildsen P.C., and Baumbach L. US-guided fine needle aspiration versus coarse needle biopsy of thyroid nodules. Eur. J. Ultrasound 13 (2001) 1-5
65. Mehrotra P., Hubbard J.G., Johnson S.J., Richardson D.L., Bliss R., and Lennard T.W. Ultrasound scan-guided core sampling for diagnosis versus freehand FNAC of the thyroid gland. Surgeon 3 (2005) 1-5
66. Carpi A., Sagripanti A., Nicolini A., Santini S., Ferrari E., Romani R., et al. Large needle aspiration biopsy for reducing the rate of inadequate cytology on fine needle aspiration specimens from palpable thyroid nodules. Biomed. Pharmacother. 52 (1998) 303-307
67. Kelman A.S., Rathan A., Leibowitz J., Burstein D.E., and Haber R.S. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid 11 (2001) 271-277
68. Barbaro D., Simi U., Lopane P., Pallini S., Orsini P., Piazza F., et al. Thyroid nodules with microfollicular findings reported on fine-needle aspiration: invariably surgical treatment?. Endocr. Pract. 7 (2001) 352-357
69. Deandrea M., Motta M., Divito L., Mormile A., Gallone G., Grassi A., et al. Thyroid cytology and risk of thyroid cancer: differences among indeterminate specimens. Endocr. Pract. 10 (2004) 330-334
70. Alaedeen D.I., Khiyami A., and McHenry C.R. Fine-needle aspiration biopsy specimen with a predominance of Hϋrthle cells: a dilemma in the management of nodular thyroid disease. Surgery 138 (2005) 650-656
71. Baloch Z.W., Fleisher S., LiVolsi V.A., and Gupta P.K. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 26 (2002) 41-44
72. Tuttle R.M., Lemar H., and Burch H.B. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8 (1998) 377-383
73. Tyler D.S., Winchester D.J., Caraway N.P., Hickey R.C., and Evans D.B. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 116 (1994) 1054-1060
74. Davis N.L., Gordon M., Germann E., Robins R.E., and McGregor G.I. Clinical parameters predictive of malignancy of thyroid follicular neoplasms. Am. J. Surg. 161 (1991) 567-569
75. Smith J., Cheifetz R.E., Schneidereit N., Berean K., and Thomson T. Can cytology accurately predict benign follicular nodules?. Am. J. Surg. 189 (2005) 592-595
76. Carpi A., Nicolini A., Sagripanti A., Righi C., Fabris F.M., and Di Coscio G. Large-needle aspiration biopsy for the preoperative selection of palpable thyroid nodules diagnosed by fine-needle aspiration as a microfollicular nodule or suspected cancer. Am. J. Clin. Pathol. 113 (2000) 872-877
77. Carpi A., Nicolini A., Righi C., Romani R., and Di Coscio G. Large needle aspiration biopsy results of palpable thyroid nodules diagnosed by fine-needle aspiration as a microfollicular nodule with atypical cells or suspected cancer. Biomed. Pharmacother. 58 (2004) 351-355
78. Carpi A., Ferrari E., Toni M.G., Sagripanti A., Nicolini A., and Di Goscio G. Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a long-term study. J. Clin. Oncol. 14 (1996) 1704-1712
79. Taki S., Kakuda K., Kakuma K., Annen Y., Katada S., Yamashita R., et al. Thyroid nodules: evaluation with US-guided core biopsy with an automated biopsy gun. Radiology 202 (1997) 874-877
80. Liu Q., Castelli M., Gattuso P., and Prinz R.A. Simultaneous fine-needle aspiration and core-needle biopsy of thyroid nodules. Am. Surg. 61 (1995) 628-632
81. Quinn S.F., Nelson H.A., and Demlow T.A. Thyroid biopsies: fine-needle aspiration biopsy vs spring-activated core biopsy needle in 102 patients. J. Vasc. Interv. Radiol. 5 (1994) 619-623
82. Pisani T., Bononi M., Nagar C., Angelini M., Bezzi M., and Vecchione A. Fine needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies. Anticancer Res. 20 (2000) 3843-3847
83. Silverman J.F., West R.L., Finley J.L., Larkin E.W., Park H.K., Swanson M.S., et al. Fine-needle aspiration vs. large-needle biopsy or cutting biopsy in evaluation of thyroid nodules. Diagn. Cytopathol. 2 (1986) 25-30
84. Chen H., Nicol T.L., and Udelsman R. Follicular lesions of the thyroid. Does frozen section evaluation alter operative management?. Ann. Surg. 222 (1995) 101-106
85. Carling T., and Udelsman R. Follicular neoplasms of the thyroid: what to recommend. Thyroid 15 (2005) 583-587
86. Carpi A., Nicolini A., Gross M.D., Fig L.M., Shapiro B., Fanti S., et al. Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule. Biomed. Pharmacother. 59 (2005) 517-520
87. Vierhapper H., Niederle B., Bieglmayer C., Kaserer K., and Baumgartner-Parzer S. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15 (2005) 1267-1272
88. Gibelin H., Essique D., Jones C., Levillain P., Marechaud R., and Kraimps J.L. Increased calcitonin level in thyroid nodules without medullary carcinoma. Br. J. Surg. 92 (2005) 574-578
89. Choi K.U., Kim J.Y., Park D.Y., Lee C.H., Sol M.Y., Han K.T., et al. Recommendations for the management of cystic thyroid nodules. ANZ J. Surg. 75 (2005) 537-541
90. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115 (2005) 1074-1078
91. Nair N., Agrawal A., and Nayak U.N. Detection of thyroid carcinoma in wall of a cystic lesion by FDG-PET. Clin. Nucl. Med. 30 (2005) 647-648
92. 18FDG-PET/CT. Surgery 138 (2005) 1166-1175
93. Goodman N.W. Criticizing evidence-based medicine. Thyroid 10 (2000) 157-160
94. Davies T.F. Is consensus a good thing in the management of thyroid nodules?. Thyroid 16 (2006) 205
95. Frates M.C., Benson C.B., Charboneau J.W., Cibas E.S., Clark O.H., Coleman B.G., et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 237 (2005) 794-800
96. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
97. Gharib H., Papini E., Valcavi R., and and the AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associzione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 12 (2006) 63-102
98. H.J. B., and D.S. D. The endocrinologists' view of ultrasound guidelines for fine needle aspiration. Thyroid 16 3 (2006) 207-208
99. Finley D.J., Lubitz C.C., Wei C., Zhu B., and Fahey T.J. Advancing the molecular diagnosis of thyroid noudles: defining benign lesions by molecular profiling. Thyroid 15 (2005) 562-568
100. Hu S., Ewertz M., Tufano R.P., Brait M., Carvalho A.L., Liu D., et al. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J. Clin. Endocrinol. Metab. 91 1 (2006) 98-104
101. Kebebew E., Peng M., Reiff E., Duh Q.Y., Clark O.H., and McMillan A. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Surgery 138 (2005) 1102-1110
102. Sobrinho-Simoes M., Preto A., Sofia Rocha A., Castro P., Maximo V., Fonseca E., et al. Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch. 447 (2005) 787-793
103. Xing M., Cohen Y., Mambo E., Tallini G., Udelsman R., Ladenson P.W., et al. Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res. 64 (2004) 1664-1668
104. Xing M., Usadel H., Cohen Y., Tokumaru Y., Guo Z., Westra W.B., et al. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res. 62 (2003) 2316-2321
105. Cohen Y., Xing M., Mambo E., Guo Z., Wu G., Trink B., et al. BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst. 95 (2003) 625-627
106. Xing M., Tufano R.P., Tufano A.P., Basaria S., Ewertz M., Rosenbaum E., et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J. Clin. Endocrinol. Metab. 89 (2004) 282-2867
107. Xing M., Westra W.H., Tufano R.P., Cohen Y., Rosenbaum E., Rhoden K.J., et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J. Clin. Endocrinol. Metab. 90 (2005) 6373-6379
108. Rosenbaum E., Hosler G., Zahurak M., Cohen Y., Sidransky D., and Westra W.H. Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma. Mod. Pathol. 18 (2005) 898-902
109. Collins B.J., Schneider A.B., Prinz R.A., and Xu X. Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure. Thyroid 16 (2006) 61-66
110. Ashery U., Yizhar O., Rotblat B., Elad-Sfadia G., Barkan B., Haklai R., et al. Spatiotemporal organization of Ras signaling: rasosomes and the galectin switch. Cell Mol. Neurobiol. (2006) [Epub ahead of print]
111. Figge J., del Rosario A.D., Gerasimov G., Dedov I., Bronstein M., Troshina K., et al. Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp. Mol. Pathol. 61 (1994) 203-211
112. Bartolazzi A., Gasbarri A., Papotti M., Bussolati G., Lucante T., Khan A., et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357 (2001) 1644-1650
113. Maruta J., Hashimoto H., Yamashita H., Yamashita H., and Noguchi S. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma. Diagn. Cytopathol. 31 (2004) 392-396
114. Carpi A., Naccarato A., Iervasi G., Nicolini A., Benlacqua G., Viacava P., et al. Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA cytology. Br. J. Cancer 95 2 (2006) 204-209 Epub 2006 Jun 27
115. Kondo T., Ezzat S., and Asa S.L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat. Rev. Cancer 6 (2006) 292-306
116. Rocha A.S., Soares P., Seruca R., Maximo V., Matias-Guiu X., Cameselle-Teijero J., et al. Abnormalities of E-cadherin/catenin complex in classical papillary thyroid carcinoma and its diffuse sclerosing variant. J. Pathol. 194 (2001) 358-366
117. Zhu Z., Gandhi M., Nikiforova M.N., Fischer A.H., and Nikiforova Y.E. Molecular profile and clinico-pathological features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am. J. Clin. Pathol. 120 (2003) 71-77
118. Wreesmann V.B., Ghossein R.A., Hezel M., Banerjee D., Shaha A.R., Tuttle R.M., et al. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 40 (2004) 355-364
119. Thomas G.A., Bunnell H., Cook H.A., Williams E.D., Nerovnya A., Cherstvoy E.D., et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J. Clin. Endocrinol. Metab. 84 (1999) 4232-4238
120. Castro P., Rebocho A.P., Soares R.J., Magalhaes J., Roque L., Trovisco V., et al. PAX8-PPARγ rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 91 (2006) 213-220
121. Baloch Z.W., Tam D., Langer J., Mandel S., LiVolsi V.A., and Gupta P.K. Ultrasound-guided fine-needle aspiration biopsy of the thyroid: role of on-site assessment and multiple cytologic preparations. Diagn. Cytopathol. 23 (2000) 425-429
122. Carcangiu M., Zampi G., Pupi A., Castagnoli A., and Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55 (1985) 805-828
123. Rosen J., He M., Umbricht C., Alexander R., Dackiw A.P.B., Zeigler M.A., et al. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Surgery 138 (2005) 1050-1057
124. Weber F., Shen L., Aldred M.A., Morrison C.D., Frilling A., Saji M., et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J. Clin. Endocrinol. Metab. 90 (2005) 2512-2521
125. Kammori M., Nakamura K., Hashimoto M., Ogawa T., Kamminishi M., and Takubo K. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization. Int. J. Oncol. 22 (2003) 985-991
126. Umbricht C.B., Conrad G.T., Clark D.P., Westra W.H., Smith D.C., Zahurak M., et al. human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin. Cancer Res. 10 (2004) 5762-5768
127. Ito Y., Yoshida H., Tomoda C., Uruno T., Takamura Y., Miya A., et al. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT). Anticancer Res. 25 (2005) 509-514
128. Eng C., Kiuru M., Fernandez M.J., and Aaltonen L.A. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat. Rev. Cancer 3 (2003) 193-202
129. Lewis P.D., Baxter P., Griffiths A.P., Parry J.M., and Skibinski D.O.F. Detection of damage to the mitochondrial genome in the oncocytic cells of Warthins tumour. J. Pathol. 191 (2000) 274-281
130. Savagner F., Mirebeau D., Jacques C., Guyetant S., Morgan C., Franc B., et al. PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma. Biochem. Biophys. Res. Commun. 310 (2003) 779-784
131. Baris O., Savagner F., Nasser V., Loriod B., Granjeaud S., Guyetant S., et al. Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors. J. Clin. Endocrinol. Metab. 89 (2004) 994-1005
132. Jacques C., Baris O., Prunier-Mirebeau D., Savagner F., Rodien P., Rohmer V., et al. Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J. Clin. Endocrinol. Metab. 90 (2005) 2314-2320
133. Maximo V., Botelho T., Capela J., Soares P., Lima J., Taveira A., et al. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hϋrthle cell) tumours of the thyroid. Br. J. Cancer 92 (2005) 1892-1898